Keymed Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	17,838	15,746	8,516	13,586	14,174	9,651
Market Cap Growth	76.84%	84.90%	-37.32%	-4.15%	46.87%	-
Enterprise Value	16,575	13,639	6,526	10,725	10,331	15,170
Last Close Price	60.55	53.45	30.90	49.10	51.00	34.50
PS Ratio	22.38	19.75	18.69	34.83	125.30	71.30
PB Ratio	5.78	5.10	3.23	4.13	3.76	2.16
P/TBV Ratio	5.79	5.12	3.25	4.13	3.76	2.15
EV/Sales Ratio	20.79	17.11	14.32	27.49	91.33	112.08
Debt / Equity Ratio	0.28	0.28	0.30	0.14	0.04	0.01
Net Debt / Equity Ratio	-0.41	-0.41	-0.57	-0.77	-0.91	-0.96
Net Debt / EBITDA Ratio	1.93	1.93	2.55	5.67	5.85	10.02
Net Debt / FCF Ratio	-	-	1.41	3.37	4.49	9.02
Asset Turnover	0.18	0.18	0.11	0.09	0.03	0.05
Inventory Turnover	0.55	0.55	0.13	0.66	0.07	1.02
Quick Ratio	2.42	2.42	3.04	8.80	8.45	31.55
Current Ratio	2.90	2.90	3.30	9.36	8.72	31.96
Return on Equity (ROE)	-19.91%	-19.91%	-18.85%	-11.31%	-8.69%	-305.24%
Return on Assets (ROA)	-10.37%	-10.37%	-10.23%	-7.32%	-8.65%	-10.09%
Return on Capital Employed (ROCE)	-19.60%	-19.60%	-20.70%	-12.80%	-15.30%	-9.40%
Earnings Yield	-3.26%	-3.69%	-6.44%	-2.91%	-2.46%	-49.44%
FCF Yield	-	-	-12.46%	-5.53%	-5.43%	-4.92%
Buyback Yield / Dilution	-4.46%	-4.46%	-0.22%	-0.09%	-62.34%	-139.72%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.